We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

99 hedge funds and large institutions have $690M invested in Heron Therapeutics in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

151% more call options, than puts

Call options by funds: $21.1M | Put options by funds: $8.42M

134.39% more ownership

Funds ownership: 0% → 134.39% (+134%)

80% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 10

13% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 30

9% more funds holding

Funds holding: 91 → 99 (+8)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

22% less capital invested

Capital invested by funds: $881M → $690M (-$191M)

Holders
99
Holders Change
+8
Holders Change %
+8.79%
% of All Funds
2.48%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
18
Increased
34
Reduced
30
Closed
10
Calls
$21.1M
Puts
$8.42M
Net Calls
+$12.7M
Net Calls Change
+$7.51M

Top Buyers

1
BC
Broadfin Capital
New York
+$16.5M
2
HCMT
Highland Capital Management (Texas)
Texas
+$14.3M
3
JHIU
Janus Henderson Investors US
Colorado
+$8.5M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$5.13M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$5.04M

Top Sellers

1
Invesco
Invesco
Georgia
-$34.3M
2
PHS
PFM Health Sciences
California
-$10.3M
3
BBA
Baker Bros. Advisors
New York
-$7.43M
4
RI
RTW Investments
New York
-$6.66M
5
Asset Management One
Asset Management One
Japan
-$4.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$101M -$789K -50,280 -0.6%
TCM
2
Tang Capital Management
California
$81.2M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$76.9M +$322K +20,545 +0.4%
JHIU
4
Janus Henderson Investors US
Colorado
$59.9M +$8.5M +542,007 +13%
BC
5
Broadfin Capital
New York
$51.1M +$16.5M +1,049,587 +37%
KCM
6
Kingdon Capital Management
New York
$36.9M +$1.84M +117,164 +4%
PHS
7
PFM Health Sciences
California
$35.8M -$10.3M -656,975 -19%
BBA
8
Baker Bros. Advisors
New York
$31.2M -$7.43M -473,681 -17%
CAM
9
Cormorant Asset Management
Massachusetts
$25.6M +$2.82M +180,000 +10%
HCMT
10
Highland Capital Management (Texas)
Texas
$20.5M +$14.3M +912,086 +140%
State Street
11
State Street
Massachusetts
$17.9M +$4.24M +270,022 +25%
Vanguard Group
12
Vanguard Group
Pennsylvania
$17.5M +$417K +26,560 +2%
VM
13
VHCP Management
New York
$14.4M – – –
BFA
14
BlackRock Fund Advisors
California
$13.4M +$2.22M +141,735 +16%
BIT
15
BlackRock Institutional Trust
California
$10.9M +$11.7K +748 +0.1%
Invesco
16
Invesco
Georgia
$7.67M -$34.3M -2,187,837 -79%
RCMNY
17
Rubric Capital Management (New York)
New York
$7.21M +$8.63M +550,000 New
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$6.86M +$5.13M +327,255 +167%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$6.37M +$5.04M +321,445 +195%
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$5.4M -$85.3K -5,439 -1%
VMI
21
VHCP Management II
New York
$5.32M – – –
Northern Trust
22
Northern Trust
Illinois
$4.8M +$132K +8,420 +2%
PAM
23
Panagora Asset Management
Massachusetts
$3.59M +$1.13M +72,316 +36%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$3.46M +$149K +9,518 +4%
Millennium Management
25
Millennium Management
New York
$3.37M +$4.03M +257,062 New
1
2 3 4 5

HRTX Hedge Fund Activity: Q4 2016 in Review

99 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2016, worth a combined $690M — down 22% from $881M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new HRTX positions and 10 closed out — a net gain of 8 holders — while 34 added to existing stakes and 30 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $16.5M. The largest seller was Invesco, cutting an estimated $34.3M.

  • 99 institutional investors held Heron Therapeutics (HRTX) as of Q4 2016, up from 91 in Q3 2016.
  • Funds reported $690M of Heron Therapeutics stock for Q4 2016, down 22% quarter-over-quarter.
  • 18 funds opened new Heron Therapeutics positions in Q4 2016 and 10 closed out, a net change of +8 holders.
  • The largest Heron Therapeutics buyer in Q4 2016 was Broadfin Capital, an estimated $16.5M added.
  • The largest Heron Therapeutics seller in Q4 2016 was Invesco, an estimated $34.3M sold.

Based on aggregated 13F filings for Q4 2016.